02/10/2025
7:30 AM | INmune Bio (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/15/2025
2:41 PM | INmune Bio (Subject)
Praetorian PR LLC (Filed by)
| Form SCHEDULE 13G | |
11/13/2024
5:08 AM | INmune Bio (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/01/2024
3:23 PM | INmune Bio (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/31/2024
3:00 PM | INmune Bio (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/28/2024
3:00 PM | INmune Bio (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/25/2024
9:15 AM | HIGHBRIDGE CAPITAL MANAGEMENT LLC (Filed by)
INmune Bio (Subject)
| Form SC 13G | |
10/24/2024
3:00 PM | INmune Bio (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/16/2024
7:47 PM | INmune Bio (Issuer)
Moss David J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/16/2024
7:48 PM | INmune Bio (Issuer)
Tesi Raymond Joseph (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/16/2024
9:11 AM | INmune Bio (Filer)
| Form 424B5 | |
Get the Latest News and Ratings for INMB and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for INmune Bio and its competitors with MarketBeat's FREE daily newsletter. |
09/16/2024
9:15 AM | INmune Bio (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/07/2024
11:15 PM | INmune Bio (Filer)
| Form EFFECT | |
06/26/2024
7:00 AM | INmune Bio (Issuer)
Juda Scott (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2024
3:05 PM | INmune Bio (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/12/2024
3:30 PM | INmune Bio (Issuer)
Tesi Raymond Joseph (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/29/2024
3:05 PM | INmune Bio (Filer)
| Form DEF 14A | |
05/10/2024
6:46 PM | INmune Bio (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/01/2024
3:05 PM | INmune Bio (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
04/26/2024
3:26 PM | INmune Bio (Filer)
| Form 424B5 | |
04/25/2024
3:35 PM | INmune Bio (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/24/2024
1:07 PM | INmune Bio (Issuer)
Juda Scott (Reporting)
| Form 4/A | |
04/24/2024
1:08 PM | INmune Bio (Issuer)
Lowdell Mark William (Reporting)
| Form 4/A | |
04/24/2024
1:08 PM | INmune Bio (Issuer)
Tesi Raymond Joseph (Reporting)
| Form 4/A | |
04/24/2024
1:10 PM | INmune Bio (Issuer)
Moss David J (Reporting)
| Form 4/A | |
04/23/2024
4:53 PM | INmune Bio (Issuer)
Juda Scott (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/23/2024
4:54 PM | INmune Bio (Issuer)
Lowdell Mark William (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/23/2024
4:54 PM | INmune Bio (Issuer)
Moss David J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/23/2024
4:55 PM | INmune Bio (Issuer)
Tesi Raymond Joseph (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/22/2024
4:09 PM | INmune Bio (Filer)
| Form 424B5 | |
04/22/2024
4:10 PM | INmune Bio (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/09/2024
3:58 PM | INmune Bio (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/28/2024
3:06 PM | INmune Bio (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
